Clinical study of bilateral uterine artery embolization versus surgical resection in the treatment of uterine arteriovenous malformation

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100048193

Enrollment

Unknown

Registered

2021-07-04

Start date

2021-07-01

Completion date

Unknown

Last updated

2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine arteriovenous malformation

Interventions

Experimental group:Uterine arterial embolization

Control group:Surgical resection

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Patients with clear diagnosis of UAVM from clinical and imaging data; 2. People at risk of abnormal uterine bleeding or who are bleeding; 3. Clinical conservative treatment failed.

Exclusion criteria

Exclusion criteria: 1. Allergic to iodine; 2. Poor coagulation function, INR > 1.5, or undergoing anticoagulant therapy or known hemorrhagic disease; 3. Severe liver and kidney dysfunction (transaminase > 5 times the upper limit of normal, creatinine > 2mg/L); 4. Complicated pregnancy and neoplastic diseases; 5. Comorbidity or social environment that may cause subjects to fail to follow the study plan or even endanger patient safety.

Design outcomes

Primary

Measure	Time frame
Intraoperative blood loss;	—

Secondary

Measure	Time frame
The operation time;Surgical success rate;Safety evaluation;	—

Countries

China

Contacts

Public ContactCao Guangshao

Henan Provincial People's Hospital

yajuncao98@126.com+86 15093103069

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026